Word on the street: These two IPOs might be worth investing in
Yahoo Finance’s On the Move panel discuss the latest headline making news stories. …read more […]
Yahoo Finance’s On the Move panel discuss the latest headline making news stories. …read more […]
The number of jobs lost due to the coronavirus shutdown continue to mount, with the latest weekly total of Americans applying for unemployment benefits coming in at 1.3 million. Yahoo Finance’s Zack Guzman breaks it down. …read more […]
Distillate Capital recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Distillate Capital’s U.S. Fundamental Stability & Value (U.S. FSV) strategy’s year-to-date decline of 1.19% through Q2 2020, is ahead of the comparable drop of 3.08% for the S&P 500 and 15.1 percentage points above the -16.3% return […] …read more […]
Distillate Capital recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Distillate Capital’s U.S. Fundamental Stability & Value (U.S. FSV) strategy’s year-to-date decline of 1.19% through Q2 2020, is ahead of the comparable drop of 3.08% for the S&P 500 and 15.1 percentage points above the -16.3% return […] …read more […]
Yahoo Finance’s On the Move panel breaks down the latest tickers moving the stock market with ‘Stocks on the Move”. …read more […]
Occidental Petroleum Corporation (NYSE:OXY) shareholders will doubtless be very grateful to see the share price up 41… …read more […]
Jonathan Silver Affinity Solutions CEO joins the On the Move panel to discuss the latest retail sales increase for the month of June.
…read more […]
COVID-19 has turned rates on their heads, and they’re now below 3% in a key survey. …read more […]
With the public desperate for a solution to COVID-19, Moderna’s (MRNA) status has increased to such an extent that any good news coming out of its HQ ripples across the whole market. Moderna can take partial credit for the S&P 500’s uptick on Wednesday, following news of the positive development in its COVID-19 vaccine program.A study published in the New England Journal of Medicine showed that in the Phase 1 study of the biotech’s experimental vaccine mRNA-1273, all 45 patients produced antibodies to the coronavirus.Moreover, participants who received two 100-microgram doses of the vaccine (patients were given either 250, 100, …read more […]
On July 5, 2020, NZS Capital released its Q2 2020 Investor Letter, a copy of which you can download here. The NZS Global Growth strategy returned 39.95% for the second quarter of 2020. Meanwhile, the benchmark Morningstar Global Markets GR index gained 19.79%. You should check out NZS Capital’s top 5 stock picks for investors […] …read more […]
Confused by the current financial landscape? You’re not alone. Unemployment is high, the Street is expecting a rough earnings season, yet in the face of this bad news, stocks have been charging forward. Add to the mix a rapidly rising rate of new COVID-19 infections, and you get a sense of the market’s clear disconnect. In times like these, traditional metrics alone might not tell the full story. You need other strategies to do the job.The activity of insiders can act as a more reliable trading signal. Who are these people in the know? They are the corporate officers and …read more […]
Yahoo Finance’s Ines Ferre joins Yahoo Finance’s Alexis Christoforous and Brian Sozzi on The First Trade to break down the latest movement in shares of AstraZeneca. …read more […]
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […] …read more […]
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […] …read more […]
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.